Hofseth Biocare ASA (HBC) announces that it has completed its Generally Recognized as Safe (GRAS) self-affirmation approval for its unique Salmon Protein Hydrolysate specially designed for human nutrition, ProGo™.
Hofseth Biocare ASA has developed a unique separation technology to isolate whole body salmon protein into a fine powder form at high purity levels. ProGo is the first significant hydrolysate from salmon to obtain GRAS status and successfully addresses increasing world protein demand for human nutrition.
HBC is also the first company to build the commercial capacity needed to yield a market-relevant volume of this protein hydrolysate for global human nutrition needs. Furthermore, ProGo’s sensory and functional characteristics make it an easy ingredient to work with, unlike other highly hydrolyzed protein sources on the market.
A committee of independent experts critically reviewed efficacy and toxicity data for ProGo. The committee found ProGo matches the highest quality standard for a protein hydrolysate and concluded that its use should be Generally Recognized as Safe. ProGo's self-affirmed GRAS status sets the stage for a new standard in protein hydrolysates derived from fish destined for human consumption.
Lucas Altepost, Hofseth Biocare's executive vice president of sales and marketing, states, “GRAS designation resonates strongly in this industry and establishes HBC as an industry leader in being the first to introduce protein hydrolysate isolates derived from fish into the human nutrition market."
ProGo is distributed by Roxlor and will be on display at SupplySide West booth number 27032. For more information on ProGo™ contact [email protected]
Hofseth BioCare ASA is a Norwegian biomarine company with the key objective to provide high value added biomarine ingredients for human applications. The Company is founded on the core value of sustainability and optimal use of natural resources. Through innovative production technology and logistics, Hofseth BioCare is able to preserve the quality of protein, calcium and oil extracted from fish off-cuts. Products that previously could only be used as animal feed can now be made suitable for human consumption. Hofseth BioCare's objective is thus to contribute to efficient use of marine resources and entering the higher profit market of quality ingredients for human applications.
Roxlor is based out of Wilmington, Del., and specializes in the manufacture and distribution of innovative branded ingredients for various categories in the nutraceutical and cosmeceutical markets. Other ingredients marketed by Roxlor include Cynatine® FLX (joint health), Cynatine® HNS (internal beauty), EnzyBoost® (improved digestion and systemic enzyme complex), Immunel™ (improved immune system), Tegricel® (helps regenerated intestinal and gastric mucosa and provide allergy relief). More information at roxlor.com.